Karoline Kollmann

8PUBLICATIONS
60CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursHaematologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 14, 2026
CDK6 inactivation counteracts CALR-mutant-induced MPN evolution and sensitizes MPN stem cells to interferon-α treatment.

|Aug 27, 2025
Mitochondrial ROS drive foam cell formation via STAT5 signaling in atherosclerosis.

Laura Boccuni, Frieda Marka, Manuel Salzmann

|Aug 21, 2024
RNA sequestration in P-bodies sustains myeloid leukaemia.

Srikanth Kodali, Ludovica Proietti, Gemma Valcarcel

|Apr 29, 2024
Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells.

Isabella M Mayer, Eszter Doma, Thorsten Klampfl

|Mar 25, 2022
CDK6 Degradation Is Counteracted by p16<sup>INK4A</sup> and p18<sup>INK4C</sup> in AML.

Belinda S Schmalzbauer, Teresemary Thondanpallil, Gerwin Heller

|Dec 01, 2020
CDK4/6 and MAPK-Crosstalk as Opportunity for Cancer Treatment.

Lisa Scheiblecker, Karoline Kollmann, Veronika Sexl

Pageof 2

Frequent Collaborators

4 joint publications

Veronika Sexl

3 joint publications

Alessia Schirripa

2 joint publications

Iris Z Uras

2 joint publications

Isabella Maria Mayer